Stock listing
3G0 Stock Price, News, Filings & Events — Altimmune, Inc.
Selected listing: 3G0 · TRADEGATE · EUR · DE
This page tracks Altimmune, Inc.'s 3G0:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 3G0:TRADEGATE. 3G0:TRADEGATE is the stock-level entry point for investors researching Altimmune, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 3G0:TRADEGATE
- Asset type
- Stock
- Market cap
- $605.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TRADEGATE
- Currency
- EUR
Altimmune, Inc. 3G0:TRADEGATE stock context
This page tracks Altimmune, Inc.'s 3G0:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 3G0:TRADEGATE. 3G0:TRADEGATE is the stock-level entry point for investors researching Altimmune, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Altimmune, Inc.
Altimmune Announces Second Quarter 2026 Financial Results and Business Update
August 12, 2026
Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
August 5, 2026
Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH
August 3, 2026
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
July 30, 2026
Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder
July 28, 2026
Altimmune, Inc. earnings calls
Altimmune, Inc. (ALT) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q4 2025 Earnings Call
March 5, 2026 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Altimmune, Inc. (ALT) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Altimmune, Inc.
Altimmune, Inc. investor report
Review AI stock analysis and investor report context for 3G0:TRADEGATE.
Altimmune, Inc. company profile
View the public company page for Altimmune, Inc. on 6ix.
Altimmune, Inc. news
Read company news and market updates connected to Altimmune, Inc..
Altimmune, Inc. investor events
Find investor webinars, events, and replay context for Altimmune, Inc..
Alternate listings
ALT:NASDAQ
US · USD
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
3G0:GETTEX
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
A2N5Z6:LS
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
A2N5Z6:LSX
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
ALT1:BMV
MX · MXN
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
ALT1:BIVA
MX · MXN
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
ALT:BOATS
US · USD
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
0A4C:LSE
GB · USD
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
3G0:DUS
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
3G0:FWB
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
3G0:HAM
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.
3G0:MUN
DE · EUR
Alternate listing for Altimmune, Inc.; the primary context on this page is 3G0:TRADEGATE.